Clinical Trial Update: Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model

View source ↗

Summary

A completed clinical trial shows that metabolic dysfunction-associated fatty liver disease impairs the quality of intraoperative indocyanine green fluorescence …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholecystitis
• Cholelithiasis
• Gallbladder Polyp
• Metabolic Dysfunction-associated Fatty Liver Disease

Snippet

Sponsor: Zhujiang Hospital | Conditions: MAFLD, Cholecystitis | Status: COMPLETED